Windlas Biotech Q4 Results

  • BSE: 543329
  • NSE: WINDLAS
  • ISIN: INE0H5O01029
  • Sector: Biotechnology & Drugs
BSE
1,042.7580.30 (8.34%)
Volume19.86 K
Updated: Mon 25 Nov, 2024 | 15:29:52
NSE
1,041.880.10 (8.33%)
Volume2.10 L
Updated: Mon 25 Nov, 2024 | 15:43:55
Today: 962.00
1,146.00
52-Wk: 397.90
1,197.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Windlas Biotech Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 171.28119.70-%140.71-%
    Selling/ General/ Admin Expenses Total 22.8517.74-%18.23-%
    Depreciation/ Amortization 3.543.14-%3.57-%
    Other Operating Expenses Total 19.2812.29-%17.17-%
    Total Operating Expense 152.82108.89-%127.84-%
    Operating Income 18.4710.81-%12.87-%
    Net Income Before Taxes 22.6312.82-%15.04-%
    Net Income 16.999.19-%11.44-%
    Diluted Normalized EPS 8.144.23-%5.38-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts